NCT02163837View on ClinicalTrials.gov

Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Hepatic Encephalopathy
Interventions
DRUG

rifaximine

Trial Locations (1)

1000

CHU St Pierre, Brussels

All Listed Sponsors
lead

Centre Hospitalier Universitaire Saint Pierre

OTHER

NCT02163837 - Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy | Biotech Hunter | Biotech Hunter